News › Industry News, News, Patient Care

WeightWatchers Launches Program for Users of Ozempic and Other Weight-loss Drugs

December 18, 2023
Scale and measuring tape

For those who thought Ozempic would spell the end of diet programs, think again.

WeightWatchers launched WeightWatchers GLP-1, a subscription program focused on the health and nutrition needs of patients using Ozempic and Wegovy, two brands of semaglutide, a diabetes drug that has exploded in popularity for its effectiveness in helping people lose weight.

With its new membership offering, the 60-year-old diet company is hoping to stay relevant in a rapidly changing industry. Widespread use of Ozempic and Wegovy has upended the diet industry and even changed consumer eating habits. An estimated 24 million people, or 7% of the U.S. population, could be using the drugs by 2035, according to a report by Morgan Stanley Research.

Read more at CBS News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Massachusetts Med Spa Owner Pleads Guilty in Federal Counterfeit Injection Case
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics